<DOC>
	<DOCNO>NCT02258529</DOCNO>
	<brief_summary>This study evaluate overall response rate ( ORR ) complete response ( CR ) rate treatment idelalisib combination rituximab participant follicular lymphoma ( FL ) small lymphocytic lymphoma ( SLL ) receive prior treatment .</brief_summary>
	<brief_title>Idelalisib Combination With Rituximab Previously Untreated Follicular Lymphoma Small Lymphocytic Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Idelalisib</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Histologically confirm diagnosis Bcell lymphoma No previous systemic treatment lymphoma Subject demonstrate need treatment lymphoma AnnArbor Stage 2 ( noncontiguous ) , 3 , 4 disease Radiographically measurable lymphadenopathy extranodal lymphoid malignancy Adequate performance status Required baseline laboratory data within protocolspecified parameter Known history transform lymphoma diffuse large cell lymphoid malignancy Known history , clinically apparent , central nervous system ( CNS ) lymphoma leptomeningeal lymphoma Evidence ongoing systemic bacterial , fungal , viral infection time enrollment Known history druginduced liver injury , chronic active hepatitis B ( HBV ) , chronic active hepatitis C ( HCV ) , alcoholic liver disease , nonalcoholic steatohepatitis , cirrhosis liver , portal hypertension , primary biliary cirrhosis , ongoing extrahepatic obstruction cause cholelithiasis Ongoing inflammatory bowel disease Known human immunodeficiency virus ( HIV ) infection History prior allogeneic bone marrow progenitor cell solid organ transplantation Ongoing immunosuppressive therapy , include systemic corticosteroid ( &gt; 10 mg prednisone equivalent/day ) exception use topical , enteric , inhaled corticosteroid therapy comorbid condition systemic steroid autoimmune anemia and/or thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Indolent Non-Hodgkin Lymphoma</keyword>
	<keyword>FL</keyword>
	<keyword>SLL</keyword>
</DOC>